BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 33016929)

  • 21. Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.
    Bartkova J; Hoei-Hansen CE; Krizova K; Hamerlik P; Skakkebæk NE; Rajpert-De Meyts E; Bartek J
    Mol Oncol; 2014 Dec; 8(8):1667-78. PubMed ID: 25066726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
    Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
    Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.
    Neumann J; Boerries M; Köhler R; Giaisi M; Krammer PH; Busch H; Li-Weber M
    Int J Cancer; 2014 Apr; 134(8):1991-2002. PubMed ID: 24150948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ATM-Chk2-INCENP pathway activates the abscission checkpoint.
    Petsalaki E; Zachos G
    J Cell Biol; 2021 Feb; 220(2):. PubMed ID: 33355621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
    Cui Y; Palii SS; Innes CL; Paules RS
    Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
    Pabla N; Huang S; Mi QS; Daniel R; Dong Z
    J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy.
    Park Y; Chui MH; Suryo Rahmanto Y; Yu ZC; Shamanna RA; Bellani MA; Gaillard S; Ayhan A; Viswanathan A; Seidman MM; Franco S; Leung AKL; Bohr VA; Shih IM; Wang TL
    Clin Cancer Res; 2019 Sep; 25(18):5584-5594. PubMed ID: 31196855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice lacking protein phosphatase 5 are defective in ataxia telangiectasia mutated (ATM)-mediated cell cycle arrest.
    Yong W; Bao S; Chen H; Li D; Sánchez ER; Shou W
    J Biol Chem; 2007 May; 282(20):14690-4. PubMed ID: 17376776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic targeting of ARID1A-deficient cancer cells with RITA (Reactivating p53 and inducing tumor apoptosis).
    Wang Z; Zhang X; Luo Y; Song Y; Xiang C; He Y; Wang K; Yu Y; Wang Z; Peng W; Ding Y; Liu S; Wu C
    Cell Death Dis; 2024 May; 15(5):375. PubMed ID: 38811536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
    Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor.
    Morales M; Theunissen JW; Kim CF; Kitagawa R; Kastan MB; Petrini JH
    Genes Dev; 2005 Dec; 19(24):3043-54. PubMed ID: 16357220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer.
    Tsoi H; Tsang WC; Man EPS; Leung MH; You CP; Chan SY; Chan WL; Khoo US
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
    Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
    Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
    Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
    J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATM-dependent CHK2 activation induced by anticancer agent, irofulven.
    Wang J; Wiltshire T; Wang Y; Mikell C; Burks J; Cunningham C; Van Laar ES; Waters SJ; Reed E; Wang W
    J Biol Chem; 2004 Sep; 279(38):39584-92. PubMed ID: 15269203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of ATM/Chk2 by Zanthoxylum armatum DC extract induces DNA damage and G1/S phase arrest in BRL 3A cells.
    Jiang J; Huang Y; Wang W; Sun C; Liu Q; Chen Y; Hu T; Ma X; Peng C; Ma Y; Liu S; Rao C
    J Ethnopharmacol; 2022 Feb; 284():114832. PubMed ID: 34775036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway.
    Chou WC; Hu LY; Hsiung CN; Shen CY
    Carcinogenesis; 2015 Aug; 36(8):832-40. PubMed ID: 26025911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Condensin recruitment to chromatin is inhibited by Chk2 kinase in response to DNA damage.
    Zhang T; Si-Hoe SL; Hudson DF; Surana U
    Cell Cycle; 2016 Dec; 15(24):3454-3470. PubMed ID: 27792460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection.
    Shirata N; Kudoh A; Daikoku T; Tatsumi Y; Fujita M; Kiyono T; Sugaya Y; Isomura H; Ishizaki K; Tsurumi T
    J Biol Chem; 2005 Aug; 280(34):30336-41. PubMed ID: 15964848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways.
    Ho CC; Siu WY; Lau A; Chan WM; Arooz T; Poon RY
    Cancer Res; 2006 Feb; 66(4):2233-41. PubMed ID: 16489026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.